Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Warning Letter Roundup & Recap – June 28, 2016

This article was originally published in The Gray Sheet

Executive Summary

Marketer of the HemaSpot dried blood spot collection device cited for premarket reg violations; QS and premarket reg citations noted at maker of OTC iontophoresis devices; and more. FDA released warning letters to three device companies this week.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT038377

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst

Cancel